Heme Flashcards
Ipilimumab/Yervoy
CTLA-4 immune checkpoint inhibitor
Nivolumab/Opdivo
PD-1 immune checkpoint inhibitor
Axicabtagene/Yescarta
anti-CD19 CAR-T (CD28 construct)
Brexucabtagene/Tecartus
anti-CD19 CAR-T (CD28 construct)
Tisagenlecleucel/Kymriah
anti-CD19 CAR-T (41BB construct)
Lisocabtagene/Breyanzi
anti-CD19 CAR-T (41BB construct)
Ciltacabtagene/Carvykti
anti-BCMA CAR-T (41BB construct)
Idecabtagene /Abecma
anti-BCMA CAR-T (41BB construct)
What does CTLA-4 bind to?
Dendritic cell ligand B7 (CD80), which would otherwise bind to CD28; this results in immune suppression
Which is more serious - PD-1 or CTLA-4 inhibition?
CTLA-4 has more severe side effects
Combined Research:
Cornell - Supplemental Application needed
UPenn - no supplemental needed
Mount Sinai - separate residency number
NYU - physician scientist track on website but link broken; clinical investigator track also exists
Yale - separate residency number
Beth Israel - direct ABIM
Mass Gen - Stanbury direct (fellowship not automatically coupled); will not automatically consider for categorical
Brigham - apply internally
Johns Hopkins - apply internally during intern year
Boston University - yes
Columbia - nothing
Montefiore/Einstein - not cancer specialty
Dabrafenib
BRAF inhibitor
Used in combination with trametinib, a MEK inhibitor, for melanoma and glioma
Cytarabine
Pyrimidine analog - competes with cytidine and incorporates into DNA, inhibiting DNA replication and inhibiting DNA polymerase
Nelarabine
Purine analog - metabolized into ara-GTP, which competes with guanosine
Anamnestic antibody response
Delayed hemolytic transfusion reaction to RBC antigen to which patient was previously sensitized (e.g. pregnancy)
Occurs days to weeks after transfusion
ABO incompatibility would cause what key features?
- Fever, flank pain, hemoglobinuria
- DIC
- Positive Coombs test
What does capillary refill assess?
Volume status/hypovolemia
Also look at dry mucous membranes, low skin turgor
What does pallor assess?
Anemia
Also look at mucous membranes, coarseness of hair, puffiness of face, nail defects
Potential exacerbations of sickle cell trait that can lead to intravascular hemolysis, tissue ischemia, and/or pain
- Flying at high altitude
- Dehydration due to alcohol
common cancers associated with malignant pericardial effusion
Breast
Lung
Lymphoma
Kerr sign
Referred pain from diaphragm and phrenic nerve to left shoulder - from splenic rupture
How is heparin-induced thrombocytopenia diagnosed?
Immunoassay (only if high titer)
Functional assay (serotonin release assay; gold standard)
Argatroban
Direct thrombin inhibitor
Used for HIT
Fondaparinux
Indirect inhibitor of Factor Xa (similar to LMWH), does not inhibit thrombin at all
Synthetic pentasaccharide sequence
Used for HIT
Chylothorax - signs and treatment
When lymphatic flow through thoracic duct is disrupted, leading to direct leakage of chyle into pleural cavity
Pleural fluid will contain T cells, Ig, and triglycerides (chylomicrons)
Treat with thoracentesis or chest tube, limiting dietary fat, and possible thoracic duct ligation
Sickle cell priapism treatment
Aspiration from corpora cavernosa, then intracavernous injection of phenylephrine
Who most often develops inhibitors of coagulation?
- Malignancy
- Rheumatic disease
- Postpartum period
Primary symptom of drug-induced thrombocytopenia
Oropharyngeal mucositis (sore throat, erythema, ulcers)
Smudge cells
Chronic lymphocytic leukemia
Waldenstrom macroglonulinemia - symptoms
- Hyperviscosity (diploma, hearing, headache)
- Neuropathy
- Hepatosplenomegaly, LAD
> 10% clonal B cells
Cyclophosphamide
Alkylating agent
Lupus with significant renal or CNS problems, vasculitis, cancer
Hemorrhagic cystitis, bladder cancer caused by acrolein metabolite - reduce risk with fluids, frequent voiding, mesna
Sterility, myelosuppression
What is a lung consequence of sickle cell disease?
Pulmonary hypertension due to vascular remodeling
Intravascular hemolysis releases heme, which consumes nitric oxide resulting in vasoconstriction; there is also inflammation and injury
Why is acute promyelocytic leukemia an emergency?
Tumor-induced consumptive coagulopathy - via activation of tissue factor (DIC) and increased generation of plasmin (fibrinolysis)
Tumor lysis syndrome - prophylaxis and treatment
Prophylaxis: IV fluids + xanthine oxidase inhibitor (allopurinol or febuxostat) or rasburicase
Treatment: IV fluids + rasburicase